Medical Pharmaceuticals

Silver Golub & Teitell LLP Investigates Class Action Data Breach Claims Against PharMerica & BrightSpring Health Following Data Breach Affecting Almost Six Million Individuals

by

STAMFORD, Conn., May 18, 2023 /PRNewswire/ — Silver Golub & Teitell LLP (“SGT”), a leading plaintiffs’ class action law firm based in Connecticut, is currently investigating potential class action data breach claims against PharMerica Corporation (“PharMerica”) and BrightSpring Health Services, Inc., (“BrightSpring Health”) following a data breach that exposed the sensitive personal information and health information … Read more

OncoSec Announces Closing of $1.33 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

by

EWING, N.J. and SAN DIEGO, May 18, 2023 /PRNewswire/ — OncoSec Medical Incorporated (NASDAQ: ONCS) (the “Company” or “OncoSec”), a clinical-stage biotechnology company developing intratumoral immunotherapies to stimulate the patient’s immune system to target cancer cells and eradicate disease, today announced the closing of its previously announced registered direct offering of 1,408,384 shares of its … Read more

HemoShear Attends Piper Sandler Conference

by

CHARLOTTESVILLE, Va., May 18, 2023 /PRNewswire/ — HemoShear Therapeutics, Inc., a privately held clinical stage biotechnology company, participated in the Piper Sandler Spring Biopharma Symposium being held in Boston, MA, Wednesday, May 17 through Thursday, May 18, 2023. The HemoShear management team, led by Brian Wamhoff, Interim CEO, briefed institutional investors on the latest company … Read more

NexPoint’s Life Sciences Project in Plano, Texas Renamed Texas Research Quarter

by

DALLAS, May 18, 2023 /PRNewswire/ — NexPoint, a multibillion-dollar alternative investment firm, today announced that its cutting-edge life sciences real estate project known as the “TxS District,” a proposed 200-acre development in Plano, Texas, has been renamed the “Texas Research Quarter.” Originally signifying “Technology x Science,” the new Texas Research Quarter (“TRQ”) name was chosen … Read more

TPU de grado médico de primera calidad, de primera calidad, facilitados por la fábrica inteligente: ICP DAS

by

HSINCHU, 18 de mayo de 2023 /PRNewswire/ — La fabricación inteligente y el estricto control de procesos mejoran la calidad de los TPU. ICP DAS – BMP (polímeros biomédicos), un proveedor de TPU (poliuretano termoplástico) de grado médico con sede en Taiwan, actúa como líder que implementa sistemas IIoT en una fábrica inteligente para mantener … Read more

HuidaGene Therapeutics Announces Publication of the World’s First Guanine Base-Editor

by

SHANGHAI and CLINTON, N.J., May 18, 2023 /PRNewswire/ — HuidaGene Therapeutics (辉大基因; HuidaGene), a clinical-stage genome-editing company, today announced the online National Science Review published the comprehensive data from a study of the world’s first DNA base editor converting G-to-Y, glycosylase-based guanine base editor (gGBE). Company has filed an international patent application for this base … Read more

Hochwertige TPUs in medizinischer Qualität dank Smart Factory: ICP DAS

by

HSINCHU, 18. Mai 2023 /PRNewswire/ – Intelligente Fertigung und strenge Prozesskontrolle verbessern die TPU-Qualität. ICP DAS – BMP (Biomedical Polymers), ein in Taiwan ansässiger Anbieter von TPU (thermoplastischem Polyurethan) in medizinischer Qualität, fungiert als Vorreiter, der IIoT-Systeme in einer Smart Factory einsetzt, um die Chargenkonsistenz bei der TPU-Produktion aufrechtzuerhalten. Das Unternehmen wird seine hochwertigen TPUs … Read more

Página “De Bem Com a Vida”, da MDS, abre espaço para a população tirar dúvidas sobre a saúde com especialistas

by

Modernizado, o site traz informações sobre boas práticas e cuidados com a saúde, bem-estar e qualidade de vida SÃO PAULO, 18 de maio de 2023 /PRNewswire/ — Comprometida com a proteção à saúde, a MDS Brasil, uma das principais corretoras do país em gestão de benefícios, anuncia a modernização do seu portal “De Bem Com … Read more

Sector is Expected to Reach $27.63 Billion by 2030 at a CAGR of 5.29%

by

DUBLIN, May 18, 2023 /PRNewswire/ — The “Global Implantable Infusion Pumps Market Size, Trends, and Growth Opportunity, By Product Type, Application, End-User By Region and forecast till 2030” report has been added to  ResearchAndMarkets.com’s offering. The global implantable infusion pumps market was valued at USD 18.29 billion in 2022 and is slated to reach USD … Read more

New Poll Shows Americans See Benefit of Medtech in Diabetes Management, Support Government Investment in Research and Cures

by

WASHINGTON, May 18, 2023 /PRNewswire/ — A new national poll conducted by Morning Consult on behalf of AdvaMed, the medtech association, found that an overwhelming number of Americans believe medical technology plays a significant role in treating and improving the health and wellbeing of those living with diabetes, but those diagnosed with the disease struggle to … Read more